Tetra Pharm Technologies

Industry

  • Pharmaceuticals
    • Vaccines
  • Biotechnology
See more in Biomedtracker

Latest on Tetra Pharm Technologies

Scrip

Deal Watch: Vanda Gets Competing Offer From Cycle After Unsolicited Future Pak Bid

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Cycle Offers $466m For Vanda, Which Tur

Scrip

Deal Watch: Bristol Adds To Vaccines ‘Repertoire,’ Takes ‘Scenic’ View Of Cellular Pathways

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bristol Looks Into Tolerizing Vaccines,